(Q33469732)

27 July 2017

title

Multimerization of peptide mimotopes for blocking of factor VIII neutralizing antibodies (English)

1 reference

27 July 2017

Ursula Dietrich

6

0 references

Thomas Klingebiel

7

object named as

Thomas Klingebiel

1 reference

27 July 2017

Christoph Kessel

1

1 reference

27 July 2017

Wolfhart Kreuz

2

1 reference

27 July 2017

Katharina Klich

3

1 reference

27 July 2017

Karin Becker-Peters

4

1 reference

27 July 2017

Frank Vorpahl

5

1 reference

27 July 2017

Christoph Königs

8

1 reference

27 July 2017

publication date

1 August 2009

1 reference

27 July 2017

1 reference

27 July 2017

volume

4

1 reference

27 July 2017

issue

8

1 reference

27 July 2017

page(s)

1364-1370

1 reference

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

Pathogenic antibodies to coagulation factors. Part one: factor VIII and factor IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

Reduction of the inhibitory antibody response to human factor VIII in hemophilia A mice by mutagenesis of the A2 domain B-cell epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

Lower inhibitor development in hemophilia A mice following administration of recombinant factor VIII-O-phospho-L-serine complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

In vivo neutralization of a C2 domain-specific human anti-Factor VIII inhibitor by an anti-idiotypic antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

Humoral immune responsiveness to a defined epitope on factor VIII before and after B cell ablation with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

Isolation of a colon tumor specific binding peptide using phage display selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

New high-technology products for the treatment of haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

Synthetic peptide ligands of the antigen binding receptor induce programmed cell death in a human B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

Phage display for epitope determination: a paradigm for identifying receptor-ligand interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

Peptide mimotopes selected from a random peptide library for diagnosis of Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

Production of multivalent protein binders using a self-trimerizing collagen-like peptide scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

A distinct strategy to generate high-affinity peptide binders to receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

A soluble recombinant multimeric anti-Rh(D) single-chain Fv/CR1 molecule restores the immune complex binding ability of CR1-deficient erythrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

Synthetic peptides in the form of dendrimers become resistant to protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

High-dose factor VIII inhibits factor VIII-specific memory B cells in hemophilia A with factor VIII inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1alpha promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

Epitope mapping of polyclonal clotting factor VIII-inhibitory antibodies using phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

inferred from DOI database lookup

7 January 2021

based on heuristic

Stable expression of soluble therapeutic peptides in eukaryotic cells by multimerisation: application to the HIV-1 fusion inhibitory peptide C46

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200900023

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CMDC.200900023

1 reference

27 July 2017

1 reference